Abstract

Vitiligo is classified as an autoimmune hypomelanosis. The prevalence is 0.5%. In etiology, the main factor is the genetic defect of the enzymatic system melanogenesis. The article is of a review nature, it highlights modern data on the pathogenesis, classification and treatment of vitiligo. Existing methods of treatment, on average, have moderate efficiency. The main ones can be considered ultraviolet therapy, laser therapy, use of topical corticosteroids and calcineurin inhibitors.